Frank Mccormick
Director at BridgeBio Pharma, Inc. (BBIO)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $13.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 31SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 111,755766,583 held (−13%) | $65.48 | $7.3M | -0.2% |
| Oct 31SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 31,116735,467 held (−4%) | $66.20 | $2.1M | -1.3% |
| Oct 31SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 3,497731,970 held (−0%) | $67.52 | $236K | -3.2% |
| Oct 31SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 8,598723,372 held (−1%) | $68.50 | $589K | -4.6% |
| Oct 31SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 43,393679,979 held (−6%) | $69.24 | $3.0M | -5.6% |
| Oct 29SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 1,641878,338 held (−0%) | $65.00 | $107K | +0.5% |
- Sell
Director Frank Mccormick sold $7.3M of BBIO at $65.48 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Frank Mccormick sold $2.1M of BBIO at $66.20 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Frank Mccormick sold $236K of BBIO at $67.52 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Frank Mccormick sold $589K of BBIO at $68.50 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Frank Mccormick sold $3.0M of BBIO at $69.24 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Frank Mccormick sold $107K of BBIO at $65.00 — pre-scheduled 10b5-1 plan sale.